What Incentives Does the BPCA Offer to Pharmaceutical Companies?
The BPCA provides pharmaceutical companies with incentives, primarily in the form of an additional six months of market exclusivity. This exclusivity period is granted if the company conducts pediatric studies as requested by the FDA. This incentive aims to offset the cost and time associated with conducting such studies and encourages the development of pediatric-specific data.
